Conmed CNMD
NYSE CNMD
$51.37 +0.12 (+0.23%)
As of: Aug 20, 2026 · 3:59 PM EDT

Conmed (CNMD) Other Non Operating Income (2010 - 2026)

Conmed's (CNMD) quarterly Other Non Operating Income came in at $2.8 million in Q2 2026, up 775.84% YoY from $322548.5 in Q2 2025, and up 775.84% on a QoQ basis from -$418000.0 in Q2 2025.

Conmed (CNMD) Other Non Operating Income (2010 - 2026) Analysis & Trends

Conmed (CNMD) has 7 years of Other Non Operating Income data on file, last reported at $2.8 million in Q2 2026.

  • Quarterly Other Non Operating Income rose 775.84% year-over-year to $2.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $21.2 million (up 15.38% YoY) and the FY2025 annual result came in at -$3.4 million, down 37.53% from the prior year.
  • Other Non Operating Income rose to $2.8 million in Q2 2026, from -$418000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.8 million in Q2 2026 to a low of -$418000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Conmed 1.54 Bn 1.50 Bn 197.46 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.83 Mn
Jun 30, 2025 -418,000.00
Dec 31, 2014 18.78 Mn
Dec 31, 2013 -17.91 Mn
Mar 31, 2013 -300,000.00
Dec 31, 2012 -1.39 Mn
Dec 31, 2011 20.25 Mn
Jun 30, 2010 -100,000.00